ProfileGDS4718 / 225562_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 65% 67% 74% 62% 64% 54% 66% 68% 67% 63% 67% 65% 63% 68% 58% 66% 62% 57% 72% 69% 67% 64% 61% 64% 66% 49% 63% 66% 69% 62% 70% 67% 66% 66% 76% 82% 72% 67% 69% 80% 66% 71% 72% 61% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]6.4425265
GSM549102patient 115, normal, homogenized [OPG study]6.6141967
GSM549104patient 119, normal, homogenized [OPG study]7.2548574
GSM549108patient 138, normal, homogenized [OPG study]6.2999162
GSM549119patient 077, normal, homogenized [OPG study]6.3867964
GSM549133patient 032, cancer, homogenized [OPG study]5.6789654
GSM549139patient 042, cancer, homogenized [OPG study]6.5874566
GSM549099patient 107, normal, homogenized [OPG study]6.6969668
GSM549109patient 139, normal, homogenized [OPG study]6.5912667
GSM549110patient 046, normal, homogenized [OPG study]6.3181363
GSM549114patient 063, normal, homogenized [OPG study]6.6154667
GSM549122patient 082, normal, homogenized [OPG study]6.5333365
GSM549134patient 033, cancer, homogenized [OPG study]6.3248463
GSM549136patient 036, cancer, homogenized [OPG study]6.7179968
GSM549140patient 044, cancer, homogenized [OPG study]5.941658
GSM549111patient 047, normal, homogenized [OPG study]6.6047866
GSM549113patient 057, normal, homogenized [OPG study]6.2131462
GSM549132patient 031, cancer, homogenized [OPG study]5.9397157
GSM549137patient 038, cancer, homogenized [OPG study]7.0444772
GSM549142patient 047, cancer, homogenized [OPG study]6.7506169
GSM549100patient 110, normal, homogenized [OPG study]6.5951167
GSM549107patient 135, normal, homogenized [OPG study]6.420664
GSM549115patient 068, normal, homogenized [OPG study]6.1461161
GSM549116patient 072, normal, homogenized [OPG study]6.4397864
GSM549120patient 078, normal, homogenized [OPG study]6.5197466
GSM549131patient 030, cancer, homogenized [OPG study]5.3863949
GSM549118patient 074, normal, homogenized [OPG study]6.3347463
GSM549129patient 027, cancer, homogenized [OPG study]6.5719466
GSM549123patient 088, normal, homogenized [OPG study]6.7749569
GSM549124patient 006, cancer, homogenized [OPG study]6.2299762
GSM549126patient 015, cancer, homogenized [OPG study]6.8582670
GSM549128patient 025, cancer, homogenized [OPG study]6.6857867
GSM549103patient 117, normal, homogenized [OPG study]6.5016766
GSM549117patient 073, normal, homogenized [OPG study]6.508666
GSM549138patient 041, cancer, homogenized [OPG study]7.4367876
GSM549141patient 045, cancer, homogenized [OPG study]8.1615282
GSM549130patient 028, cancer, homogenized [OPG study]7.010472
GSM549101patient 111, normal, homogenized [OPG study]6.6586767
GSM549105patient 128, normal, homogenized [OPG study]6.7533669
GSM549106patient 134, normal, homogenized [OPG study]8.0556780
GSM549112patient 048, normal, homogenized [OPG study]6.5665466
GSM549125patient 011, cancer, homogenized [OPG study]6.8965871
GSM549127patient 024, cancer, homogenized [OPG study]7.171172
GSM549135patient 035, cancer, homogenized [OPG study]6.1788161